OAB-034: Evaluating the impact of cytogenetic abnormalities on treatment outcomes in patients with AL amyloidosis: subanalyses from the ANDROMEDA study
Titel:
OAB-034: Evaluating the impact of cytogenetic abnormalities on treatment outcomes in patients with AL amyloidosis: subanalyses from the ANDROMEDA study
Auteur:
Kumar, Shaji Dispenzieri, Angela Bhutani, Divaya Gertz, Morie Wechalekar, Ashutosh Palladini, Giovanni Comenzo, Raymond Fonseca, Rafael Jaccard, Arnaud Kastritis, Efstathios Schönland, Stefan Porte, Charles la Pei, Huiling Tran, NamPhuong Vermeulen, Jessica Merlini, Giampaolo